My hair journey: 2017 through the present
    Progress Pictures 9/10/2024

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily 2 years (2015-2017), resumed in 2023
    💧 Minoxidil (topical) 5% daily since 2015
    💊 Dutasteride (oral) daily 5 months (2024)
    💊 Supplements (oral) daily since 2023
    💧 Dermarolling (topical) weekly since 2024
    💧 Nizoral (topical) weekly since 2023
    the tone is 😐 neutral with some growth results.

    Other terms

    A user shared their hair loss journey from 2017 to 2024, detailing the use of finasteride, minoxidil, dutasteride, supplements, and dermarolling. They experienced significant hair loss after stopping finasteride in 2017, saw some regrowth after resuming treatments in 2023, and are considering a hair transplant.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Experimental and Early Investigational Drugs for Androgenetic Alopecia

      research Experimental and early investigational drugs for androgenetic alopecia

      11 citations , July 2017 in “Expert Opinion on Investigational Drugs”
      This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.

      research Pharmacological therapeutics in androgenetic alopecia

      3 citations , May 2020 in “Journal of The Korean Medical Association”
      This review discusses treatment options for androgenetic alopecia, with a focus on the better efficacy of oral finasteride and dutasteride over topical minoxidil for male pattern hair loss, but it reports no new clinical results.
      Androgenetic Alopecia: Therapy Update

      research Androgenetic Alopecia: Therapy Update

      May 2023 in “Drugs”
      This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.

      research Nonsurgical hair restoration treatment.

      13 citations , July 2019 in “PubMed”
      This article reviews various nonsurgical treatments for patterned hair loss, emphasizing options like minoxidil, finasteride, and low-level laser therapy, but does not report specific study results.

      research Natural Products Used in Male Pattern Baldness

      June 2026
      This study reviews the use of natural products, like herbal extracts and essential oils, in treating male pattern baldness, noting their potential benefits compared to conventional therapies that may carry side effects or ethical concerns.